Veeva Systems Inc.

VEEV Healthcare Health Information Services

Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.

310.30 2.73 −0.87%
Market cap
$50.7B
P/E
50.0×
Fwd P/E
26.9×
Dividend yield
—
F-score
7/9
Altman Z
13.57
Beneish M
−2.63
Dividend safety
n/a
Jan '26 Jan '25 Jan '24 Jan '23 Jan '22 Jan '21 Jan '20 Jan '19 Jan '18 Jan '17
P/E ratio
36.57 52.89 63.23 54.49 84.78 112.27 71.87 68.59 62.24 73.89
Piotroski F-Score
7 7 5 5 6 5 5 7 7 8
Altman Z-Score
13.57 17.18 17.84 16.76 26.31 34.16 23.43 24.93 18.45 14.99
P/S ratio
10.42 13.75 14.09 12.30 19.59 29.09 19.63 18.25 12.77 10.43
Altman Z″-Score (non-manufacturers)
11.21 10.62 10.10 9.78 9.64 8.71 7.88 9.35 8.60 7.56
P/FCF ratio
24.01 35.31 37.62 34.55 48.32 78.56 50.04 52.26 39.72 42.08
P/Operating CF
311.49 542.96 576.36 418.02 670.63 623.62 554.05 493.56 6,137.75 (2,751.00)
Beneish M-Score
(2.63) (2.59) (2.63) (2.64) (2.83) (2.47) (1.69) (2.51) (2.59) (2.75)
P/B ratio
4.61 6.47 7.17 7.13 12.45 18.81 13.01 12.71 9.73 8.80
Price to Tangible BV
4.93 7.06 8.04 8.30 15.30 24.84 19.83 14.08 11.32 11.10
EV/Sales
8.36 11.87 12.38 10.86 18.30 27.96 18.64 16.98 11.67 9.49
EV/EBITDA
27.80 45.17 64.52 46.18 59.93 95.02 63.66 57.90 42.36 34.71
EV/Operating CF
18.88 29.92 32.12 29.98 44.31 74.31 47.06 47.10 34.52 36.28
EV/FCF
19.28 30.49 33.07 30.51 45.15 75.50 47.53 48.64 36.29 38.28
Quick Ratio
4.81 4.44 4.17 3.86 3.65 3.18 2.74 3.52 3.27 2.84
Current Ratio
4.89 4.51 4.24 3.94 3.70 3.23 2.78 3.57 3.31 2.88
Net Debt/EBITDA
(6.83) (7.13) (8.88) (6.12) (4.20) (3.86) (3.36) (4.31) (4.01) (3.45)
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.39 0.41 0.44 0.50 0.54 0.55 0.56 0.60 0.64 0.68
Operating CF/Net income
1.56 1.53 1.73 1.60 1.79 1.45 1.45 1.35 1.54 1.86
Capex/Depreciation
(0.65) (0.67) (1.08) (0.28) (0.24) (0.16) (0.12) (0.33) (0.35) (0.25)
ROE
13.93% 13.63% 12.58% 14.72% 16.51% 19.33% 20.74% 21.44% 19.40% 13.40%
ROA
11.14% 10.78% 9.81% 11.31% 12.46% 14.29% 15.34% 15.94% 14.08% 9.56%
ROIC
87.58% 63.35% 43.49% 46.76% 58.99% 39.18% 30.90% 94.38% 68.41% 56.38%
Return on Tangible Assets
14.13% 14.38% 13.54% 16.19% 18.41% 23.05% 29.10% 21.14% 19.93% 15.06%
Average Days of Receivables
149.68 140.48 137.21 132.99 136.95 152.37 139.68 136.14 125.81 121.20
Research and Development Expense of Revenue
24.02% 25.23% 26.61% 24.14% 20.64% 20.08% 19.01% 18.42% 19.12% 17.57%
Selling, General and Administrative Expense of Revenue
22.83% 24.12% 26.57% 26.28% 24.83% 26.22% 27.59% 27.29% 27.40% 28.96%
Intangible Assets out of Total Assets
0.05 0.07 0.09 0.11 0.14 0.18 0.25 0.07 0.10 0.15
Share Based Compensation of Revenue
14.79% 15.92% 16.66% 16.33% 12.68% 12.63% 10.50% 8.86% 7.83% 7.41%
Graham Net Nets
0.19 0.13 0.11 0.11 0.06 0.04 0.04 0.06 0.08 0.08
Graham Number
74.26 59.79 46.21 41.04 34.54 29.20 22.74 17.52 12.12 7.87
Earnings Yield
2.73% 1.89% 1.58% 1.84% 1.18% 0.89% 1.39% 1.46% 1.61% 1.35%
Free Cash Flow Yield
4.16% 2.83% 2.66% 2.89% 2.07% 1.27% 2.00% 1.91% 2.52% 2.38%
Revenue per Share
19.52 16.97 14.72 13.87 12.08 9.72 7.47 5.98 4.92 4.06
Operating CF per Share
8.65 6.73 5.68 5.02 4.99 3.66 2.96 2.15 1.66 1.06
Capex per Share
(0.18) (0.13) (0.16) (0.09) (0.09) (0.06) (0.03) (0.07) (0.08) (0.06)
Free Cash Flow per Share
8.47 6.61 5.51 4.94 4.90 3.60 2.93 2.09 1.58 1.01
Cash per Share
40.09 31.82 25.09 19.97 15.50 11.04 7.35 7.56 5.43 3.82
Shareholders Equity per Share
44.08 36.03 28.93 23.92 19.00 15.04 11.27 8.58 6.46 4.81
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
44.08 36.03 28.93 23.92 19.00 15.04 11.27 8.58 6.46 4.81
Free Cash Flow
1,386.09 1,069.53 885.14 766.96 750.25 542.56 433.05 301.01 222.07 136.50
Working Capital
6,360.57 4,910.40 3,824.33 2,962.51 2,266.40 1,594.87 979.95 1,032.39 706.25 465.08
Capital Expenditures
(29.13) (20.52) (26.20) (13.51) (14.21) (8.68) (4.32) (9.82) (11.37) (7.51)
Net Current Asset Value
6,233.04 4,801.42 3,737.12 2,881.27 2,202.36 1,531.08 924.94 1,017.40 688.33 447.14
EV/EBIT
29.16 47.16 68.17 50.97 67.01 108.42 71.91 65.69 51.02 43.30
Capex to Sales
0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.02 0.01
Price to Operating Income
36.32 54.61 77.55 57.72 71.71 112.83 75.71 70.59 55.85 47.59
Other line items
Depreciation/Fixed assets
0.64 0.54 0.42 0.96 1.10 0.99 0.68 0.55 0.62 0.60
Cash ROIC
10.06% 9.74% 10.21% 11.25% 14.19% 13.81% 15.73% 12.93% 13.31% 11.65%
Accounts Receivable Turnover
2.70 2.82 2.82 2.91 2.83 2.83 2.97 3.08 3.28 3.36
Accounts Payable Turnover
22.97 22.58 18.51 19.65 23.10 19.17 21.27 30.56 33.50 33.80
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
17.57 15.88 16.98 24.96 14.75 20.76 23.37 13.56 11.99 11.93
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
1,183.73 972.83 836.88 739.81 653.00 517.05 372.05 279.80 210.42 163.81
Average Payables
34.05 30.98 36.60 31.01 21.80 21.34 14.27 8.03 6.31 5.14
Average Assets
8,159.55 6,625.34 5,357.61 4,310.38 3,431.27 2,658.92 1,962.77 1,442.05 1,073.85 811.59
Average Common Equity
6,523.56 5,238.60 4,180.54 3,313.94 2,588.98 1,965.96 1,451.67 1,071.99 779.45 578.95

Fold the line items

Columns are period end dates